Add BrightSurf on Google Email

Max Planck Institute for Biology of Ageing


Live longer

A combination of Rapamycin and Trametinib therapies significantly prolongs the life of mice by up to 30%, reducing chronic inflammation and delaying cancer onset. The unique combination achieves novel effects on gene expression, offering a potential geroprotector approach to extend human lifespan.

SourceMax Planck Institute for Biology of Ageing·JournalNature Aging·TypeExperimental study·DateMay 28, 2025

Time’s arrow

Researchers found that brief rapamycin exposure in early adulthood can prevent age-related decline and extend lifespan. The study used fruit flies and mice to test the effects of short-term drug administration, showing protection against intestinal pathology and increased health span.

SourceMax Planck Institute for Biology of Ageing·JournalNature Aging·TypeExperimental study·DateAug 29, 2022